Coralville, IA, United States of America

Robert F Mullins

USPTO Granted Patents = 4 


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Macular Degeneration by Robert F. Mullins

Introduction

Robert F. Mullins is a prominent inventor based in Coralville, IA (US). He has made significant contributions to the field of ophthalmology, particularly in the diagnosis and treatment of macular degeneration-related disorders. With a total of 4 patents to his name, Mullins is recognized for his innovative approaches to addressing vision-related health issues.

Latest Patents

Mullins' latest patents focus on diagnostics and therapeutics for macular degeneration-related disorders. One of his inventions relates to methods for diagnosing and treating these disorders, while another emphasizes the identification of genes that contribute to macular degeneration. His work aims to improve the understanding and management of these conditions, ultimately enhancing patient outcomes.

Career Highlights

Mullins is affiliated with the University of Iowa Research Foundation, where he has been instrumental in advancing research in his field. His dedication to innovation has led to breakthroughs that are vital for the treatment and prevention of macular degeneration-related disorders. His expertise and commitment to research have positioned him as a leader in ophthalmic innovation.

Collaborations

Mullins collaborates with Gregory S. Hageman, a fellow researcher in the field. Their partnership has fostered advancements in understanding the genetic factors associated with macular degeneration, further enhancing the potential for effective treatments.

Conclusion

Robert F. Mullins continues to make impactful contributions to the field of ophthalmology through his innovative patents and research efforts. His work not only addresses critical health issues but also paves the way for future advancements in the diagnosis and treatment of macular degeneration-related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…